| The
use of biotechnology in agriculture has come at a time when there are
real fears that after 5000 years of agriculture, conventional practices
have reached a plateau of production that would be unable to sustain a
projected world population of 10 billion by the year 2030 Ð that is in
just about 30 years time. But is this biotechnology the answer to our concerns and fears
about our ability to feed a burgeoning world population, especially
populations of developing and underdeveloped countries? What does the record show so far? And what are the red flags Ð
those things that alert us to stop or at least to proceed with caution? |
|
Raising the
Red Flag: Making the Right Decisions |

|
IMPLICATIONS FOR LOCAL CONSUMERS
I
am not suggesting that on these few examples we pass judgment on the
worth and value of biotechnology companies. I am however suggesting that as concerned and informed citizens
we must be aware of those things that are taking place around us that
could affect us in one way or another. We must put ourselves in the best position to make informed
decisions about the course of action |
|
RED FLAG NO. 1
The first red flag is the question of the goal and objectives of
multinational biotechnology companies.Plant science, the foundation of biotechnology in agriculture, is
now the substance of big business, patent rivalries and closely guarded
technical tricks (New Scientist, 1998).Biotechnology based multinational and giant national corporations
like Monsanto, Norvatis, Bayer or multinational network like EuropaBio,
the association of European biotechnology companies is by and large the
owners and manipulators of biotechnology.Major research work conducted in biotechnological areas are
funded, supported and conducted by these groupings with vested
interests. The stakes are high. These companies throw out the palliative
to an unsuspecting and uniformed consumer population that genetically
modified crops will feed starving millions, while conserving the
environment.
RED FLAG NO. 2
The second red flag is the extent to which the goals of genetic engineering
have been fulfilled.
Many research and biotechnology institutions/companies have
identified a number of ways in which crops can be beneficially modified
using genetic engineering technology.
These include:
-
Producing
varieties more precisely adapted to local conditions (Goal
identified by CSIRO Division of Plant Industry in Canberra,
Australia)
-
Increasing
calories in fodder plants, thus producing more meat per hectare.
(Goal identified by Novartis).
-
Producing
crops that can destroy toxins produced by moulds which account for
major crop losses annually. (Goal identified by Novartis).
-
Producing
disease resistant crops in staples of the poor e.g. sweet potato,
cassava. (Goal identified by Norvatis).
-
Improving
nutritional content of staples such as maize (Goal identified by
Monsanto).
But
few of these crops have so far emerged showing any of these adaptations. The focus on research and development so far is on cutting
expensive inputs such as pesticides, thereby increasing the profits to
farmers, specifically large-scale farmers and landowners. But small-scale farmers cannot afford these inputs for starters,
so that these crops may not help them, and further, the farmers cannot
afford the patented seeds.
Also,
the new farming practices which biotechnology companies feel would stem
from use of the new technology, for example, reduction of clearing
forested areas for subsistence farming, are not evident.
RED FLAG NO. 3
The third, and perhaps most significant, red flag is the issue of
ownership. The multinational companies control both markets and plant genes. Crop scientists must continually breed new varieties to meet the
ever-evolving threat of pests and disease.
|
In developing countries this is mainly done by government-funded
institutions.But
public sector breeders are losing funding while
companies
like Monsanto are rapidly becoming the only source for
improved
varieties. They can corner the market. For example Monsanto sells half the
maize seed in Argentina.
Public
breeders are also losing access to plant genes. The Consultative Group
for International Agricultural Research (a public funded international
agency) completed a comprehensive study of the problems posed by the
fact that the genes it needs to do its work are available only at a
price, because companies hold the patents. India refused to pay Monsanto US$8 million
for use of its Bt insecticide gene. Indian laboratories were therefore unable to produce cheap
locally bred insect-resistant crops. Indian farmers have to buy what Monsanto has to offer.
Getting
access to the gene is not the only problem developing countries have to
face. But maintaining access and attaining some degree of sustainability
of production is another major issue. For example, Monsanto owns the Terminator gene that
prevents a plant from producing viable seed, so farmers cannot save
seeds from patented, genetically modified varieties for the next
harvest. It also prevents farmers from crossing patented varieties with
other crops to create new varieties. Public sector breeders may also be under pressure to use the Terminator
to protect patented genes in exchange for access according to Debbie
Mack (New Scientist, 1998).
RED FLAG NO.
4
The
fourth red flag is the issue of genetic uniformity. This is cause for concern of farmers who as a result become more
and more dependant on multinational corporations. Their crops are more susceptible to unforeseen stress that drives
the cycle of research and development at the expense of farmers'
independence. |
We take or do not take because in the final analysis we are responsible for ourselves. Therefore, we must ask questions of ourselves and of others.
Some key questions:
- What
does this new wave of biotechnology mean for us as consumers
Ð both of the food and as users of the technology, in a
developing country?
- What are our concerns, rights, and responsibilities?
|
Overall, our concerns are no different from those expressed by consumers the world over.
|